David Amantini
14Patents
5h-index
41Co-inventors
62Inventor score
Filing activity: Oct 6, 2006 → Jan 5, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8153623B2 | Compounds | Chemistry; Metallurgy | 9 | Active |
| US8133908B2 | Heteroaryl derivatives of N-{[(1S,4S,6S)-3-(2-pyridinylcarbonyl)-3-azabicyclo[4.1.0]hept-4-yl]methyl}-2-amine | Chemistry; Metallurgy | 8 | Active |
| US7803833B2 | Compounds | Chemistry; Metallurgy | 8 | Active |
| US8093255B2 | Imidazo[1,2-A]pyrimidines as orexin receptor antagonists | Human Necessities | 8 | Active |
| US8129384B2 | Imidazo[1,2-a]pyrazines as orexin receptor antagonists | Human Necessities | 7 | Active |
| US9926281B2 | 5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis | Chemistry; Metallurgy | 4 | Active |
| US10487060B2 | 5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis | Chemistry; Metallurgy | 3 | Active |
| US11136325B2 | Pyrrolopyrimidine and pyrrolopyridine derivatives | Chemistry; Metallurgy | 0 | Active |
| US10829478B2 | 5-[3-[piperazin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 4 and 5 inhibitors for treating e.g. osteoarthritis | Chemistry; Metallurgy | 0 | Active |
| US10941117B2 | 5-[(piperazin-l-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis | Chemistry; Metallurgy | 0 | Active |
| US11564923B2 | Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders | Chemistry; Metallurgy | 0 | Active |
| US12264156B2 | Compounds and pharmaceutical compositions thereof for the treatment of diseases | Human Necessities | 0 | Active |
| US11718588B2 | 5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis | Chemistry; Metallurgy | 0 | Active |
| US10550100B2 | 5-[3-[piperzin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 4 and 5 inhibitors for treating E.G. osteoarthritis | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.